CPHI Webinar Series

The Changing Dynamics of Global API Manufacturing 

17th September, 2024
3pm BST/ 4pm CET
What will this webinar address?

Across the globe, API manufacturing continues to be impacted by multiple forces including regulators increasing scrutiny, growing costs, and pushing traceability downstream. The industry is also experiencing increased competition, price sensitivity and the need for differentiation through efficiency, regulatory compliance or building new capabilities in biosimilars, HPAPI or ADCs for example. 

In this session, we will discuss:

  • The current landscape of API manufacturers and their changing experience and capabilities
  • How API manufacturers are growing and diversifying while managing competitive pressures
  • Understanding how major industry shifts in Chinese and Indian industries affect the turn to innovation-driven business models, and the opportunities this creates for new manufacturing hubs to emerge
  • Our panel of experts will discuss:

  • The current landscape of API manufacturers and their changing experience and capabilities
  • How API manufacturers are growing and diversifying while managing competitive pressures
  • Molly Bowman
    Head of Strategy for Pharmaceutical SCM
    Clarivate

    Molly Bowman has over fifteen years of expertise in the life sciences industry and has worked across the pharmaceutical development lifecycle. Her work involves examining trends and delivering insights to global pharmaceutical companies, regulatory bodies, and consultancies. She previously oversaw the collection, alignment and integration of information focused on active ingredient manufacturing, clinical drug development, US healthcare payers and US medical supply distribution. In her current role, she collaborates with clients to address the ever-evolving dynamics of global supply chains.

    Mike Ward
    Head of Thought Leadership, Life Sciences
    Clarivate

    As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. His actionable insights and analysis support pharma, biotech, healthcare and medtech stakeholders gain a deeper understanding of market news and trends.

    Gunjan Singh
    Head of Mature Markets API
    Dr. Reddy's

    Gunjan Singh heads the Mature Markets (US, Europe, Canada, Mexico, CIS) Sales for Dr. Reddy's. He also heads the Strategy and Product Management functions. Previously, he worked as CEO of Wanbury Ltd. Prior to that, he managed the API Business at Jubilant Pharma and Sales and Marketing at Piramal Pharma Solutions. Before his foray into pharma, Gunjan worked as a strategy consultant with Accenture Consulting. He has managed portfolio, strategy, BD, sales and P&L in various capacities and has worked across APIs, formulations and CDMO.

    This webinar is brought to you by

    Overview
    The Changing Dynamics of Global API Manufacturing 
    • 17th September, 2024
    • 3pm BST/ 4pm CET
    • 60 minutes
    • Free
    CPHI Newsletter

    Get the latest from CPHI in your inbox every week.

    You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time by clicking on the Unsubscribe link in the Newsletters or opting out on our unsubscribe page page.